When Success Rates Go Low, Cell-Based Screens Go High
To Boost Success Rates, Developers are Balancing High-Content and High-Throughput Screening
Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
Building the Ideal Bioprocessing Strategy
Searching for Innovative, Cost-Effective Product Options
Innovations in Viral Clearance
Mock Viruses, Plant Design, and Rational Testing
For full access to this article login to GEN Select now.
Biotech Embroiders Intricate Glycopatterns
Glycans Account for Some of the More Ornate Weavings from Nature's Post-Translational Loom
- Through its association with monoclonal antibody quality, safety, and efficacy, glycosylation remains a hot issue for biotech. Accordingly, improving glycosylation is a priority for companies such as Agilent Technologies, which has undertaken several initiatives to improve glycan analysis within the context of the company’s analytical systems. ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.